GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,063,000 | -47.0% | 104,085 | -21.6% | 1.16% | -43.2% |
Q2 2022 | $5,782,000 | -0.1% | 132,819 | 0.0% | 2.05% | +13.2% |
Q1 2022 | $5,786,000 | +31.4% | 132,819 | +33.0% | 1.81% | +22.6% |
Q4 2021 | $4,405,000 | -0.8% | 99,883 | -14.0% | 1.48% | +22.1% |
Q3 2021 | $4,439,000 | -13.7% | 116,183 | -10.0% | 1.21% | +0.8% |
Q2 2021 | $5,141,000 | +15.2% | 129,097 | +3.3% | 1.20% | +6.4% |
Q1 2021 | $4,462,000 | -5.1% | 125,028 | -2.2% | 1.13% | -19.5% |
Q4 2020 | $4,704,000 | -7.1% | 127,838 | -5.0% | 1.40% | -18.2% |
Q3 2020 | $5,065,000 | -6.7% | 134,558 | +1.1% | 1.71% | -11.1% |
Q2 2020 | $5,429,000 | +8.8% | 133,098 | +1.1% | 1.92% | -9.2% |
Q1 2020 | $4,990,000 | -21.7% | 131,706 | -2.9% | 2.12% | +22.7% |
Q4 2019 | $6,372,000 | +6.1% | 135,598 | -3.6% | 1.73% | +0.9% |
Q3 2019 | $6,005,000 | -1.7% | 140,698 | -7.8% | 1.71% | -1.2% |
Q2 2019 | $6,107,000 | -2.5% | 152,608 | +1.8% | 1.73% | -4.9% |
Q1 2019 | $6,263,000 | +10.8% | 149,858 | +1.3% | 1.82% | +2.5% |
Q4 2018 | $5,651,000 | -6.3% | 147,898 | -1.5% | 1.78% | +13.7% |
Q3 2018 | $6,034,000 | -9.1% | 150,224 | -8.7% | 1.56% | -5.9% |
Q2 2018 | $6,635,000 | -5.7% | 164,599 | -8.6% | 1.66% | +3.4% |
Q1 2018 | $7,033,000 | +44.1% | 180,000 | +30.8% | 1.61% | +45.0% |
Q4 2017 | $4,882,000 | -32.0% | 137,630 | -22.1% | 1.11% | -35.1% |
Q3 2017 | $7,175,000 | -4.8% | 176,730 | +1.1% | 1.71% | -9.7% |
Q2 2017 | $7,537,000 | +3.4% | 174,790 | +1.1% | 1.89% | +7.5% |
Q1 2017 | $7,286,000 | +10.1% | 172,825 | +0.6% | 1.76% | +7.3% |
Q4 2016 | $6,615,000 | -11.0% | 171,765 | -0.3% | 1.64% | -11.3% |
Q3 2016 | $7,434,000 | -3.3% | 172,365 | -2.8% | 1.85% | -2.8% |
Q2 2016 | $7,688,000 | +8.9% | 177,395 | +1.9% | 1.90% | +5.6% |
Q1 2016 | $7,059,000 | +2.6% | 174,075 | +2.1% | 1.80% | +0.9% |
Q4 2015 | $6,880,000 | +86.2% | 170,515 | +77.4% | 1.78% | +121.2% |
Q3 2015 | $3,695,000 | -6.3% | 96,100 | +1.5% | 0.81% | +30.4% |
Q2 2015 | $3,942,000 | -6.9% | 94,640 | +3.1% | 0.62% | -2.4% |
Q1 2015 | $4,234,000 | +20.5% | 91,750 | +11.6% | 0.63% | +0.2% |
Q4 2014 | $3,515,000 | – | 82,250 | – | 0.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |